Is Pfizer Inc. overvalued?

Pfizer Inc. (PFE) looks overvalued — trading about 13% above its fair value.

Overvalued

Price

$28.67

Fair value

$25.05

Current P/E

21.1

Normal P/E

18.4

Market cap

$163.40B

Dividend yield

6.1%

Return on equity

4.9%

Sector

Healthcare

Fair value compares PFE's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks